Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 09:58 am Purchase | 2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners, LP | 7,012,226 10.400% | 364,201 (+5.48%) | Filing History |
| 2023-02-13 4:41 pm Sale | 2023-02-13 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC/MA | 11,419,226 16.950% | -3,111,770 (-21.41%) | Filing History |
| 2023-02-10 4:40 pm Purchase | 2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH | BlackRock Inc. BLK | 5,329,830 7.900% | 327,467 (+6.55%) | Filing |
| 2023-02-10 4:05 pm Purchase | 2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Weiss Asset Management LP | 7,457,060 11.090% | 1,299,700 (+21.11%) | Filing History |
| 2023-02-09 11:35 am Sale | 2022-12-30 | 13G | Theravance Biopharma, Inc. TBPH | The Vanguard Group | 5,558,839 8.250% | -740,984 (-11.76%) | Filing History |
| 2023-01-30 3:06 pm Purchase | 2023-01-11 | 13G | Theravance Biopharma, Inc. TBPH | BARCLAYS PLC | 3,402,767 5.050% | 3,402,767 (New Position) | Filing History |
| 2022-09-20 4:12 pm Sale | 2022-09-16 | 13D | Theravance Biopharma, Inc. TBPH | GSK PLC | 0 0.000% | -9,644,807 (Position Closed) | Filing History |
| 2022-08-03 08:33 am Unchanged | 2022-08-03 | 13D | Theravance Biopharma, Inc. TBPH | GSK PLC | 9,644,807 12.700% | 0 (Unchanged) | Filing History |
| 2022-06-16 3:41 pm Purchase | 2022-06-08 | 13G | Theravance Biopharma, Inc. TBPH | Weiss Asset Management LP | 6,157,360 8.090% | 6,157,360 (New Position) | Filing History |
| 2022-04-21 11:08 am Purchase | 2022-03-18 | 13G | Theravance Biopharma, Inc. TBPH | ODRE 2005 SLU | 4,108,318 5.500% | 4,108,318 (New Position) | Filing History |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Point72 Asset Management, L.P. | 228,922 0.300% | -4,915,715 (-95.55%) | Filing History |
| 2022-02-14 09:43 am Purchase | 2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners, LP | 6,648,025 9.000% | 2,080,612 (+45.55%) | Filing History |
| 2022-02-11 4:49 pm Sale | 2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH | ORBIMED ADVISORS LLC | 5,456,780 7.400% | -87,432 (-1.58%) | Filing History |
| 2022-02-11 4:15 pm Purchase | 2022-02-11 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC/MA | 14,530,996 19.490% | 4,925,000 (+51.27%) | Filing History |
| 2022-02-10 4:48 pm Unchanged | 2021-11-08 | 13D | Theravance Biopharma, Inc. TBPH | GSK PLC | 9,644,807 13.100% | 0 (Unchanged) | Filing History |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH | The Vanguard Group | 6,299,823 8.550% | 1,645,514 (+35.35%) | Filing History |
| 2022-02-03 4:29 pm Purchase | 2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH | BlackRock Inc. BLK | 5,002,363 6.800% | 511,168 (+11.38%) | Filing |
| 2021-10-12 09:25 am Sale | 2021-10-08 | 13G | Theravance Biopharma, Inc. TBPH | FMR LLC | 2,670,881 3.635% | -6,936,429 (-72.20%) | Filing History |
| 2021-10-08 08:36 am Sale | 2021-09-30 | 13G | Theravance Biopharma, Inc. TBPH | Wellington Management Group LLP | 250,219 0.340% | -7,352,526 (-96.71%) | Filing History |
| 2021-09-27 4:46 pm Purchase | 2021-09-15 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners, LP | 4,567,413 6.200% | 4,567,413 (New Position) | Filing History |